RBM3 and prostate carcinoma: Its expression is reduced, for instance, in urothelialbladder cancer and nonsmall cell lungcancer but increased in epithelial ovariancancer and prostate cancer. In both instances where RBM3 is upregulated,this correlates with a favorable prognosis.